Funder
Vir Biotechnology, Inc.
GSK
Ministry of Health, Labour and Welfare of Japan.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology
Reference20 articles.
1. Gebru AA, Birhanu T, Wendimu E, et al. Global burden of COVID-19: situational analysis and review. Hum Antibodies. 2021;29(2):139–48. https://doi.org/10.3233/HAB-200420.
2. Monteiro Pires S, Wyper GMA, Wengler A, et al. Burden of disease of COVID-19: strengthening the collaboration for national studies. Front Public Health. 2022;10:907012. https://doi.org/10.3389/fpubh.2022.907012.
3. European Centre for Disease Prevention and Control. Risk factors and risk groups. 2022. https://www.ecdc.europa.eu/en/covid-19/latest-evidence/risk-factors-risk-groups. Accessed 11 May 2023.
4. World Health Organization. WHO Coronavirus (COVID-19) dashboard: global vaccination data. 2022. https://covid19.who.int. Accessed 11 May 2023.
5. World Health Organization. WHO Coronavirus (COVID-19) dashboard: Japan vaccination data. 2022. https://covid19.who.int/region/wpro/country/jp. Accessed 11 May 2023.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献